Matisse Pharmaceuticals BV was founded in 2014 in Geleen, the Netherlands. Matisse targets life-threatening inflammation by neutralizing cytotoxic components of the inflammatory system. Its main development program is the development of a medicine to fight sepsis and septic shock, which is currently in clinical phase.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Geleen
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- matisse-pharma.com
- HQ
- Geleen
Matisse Pharmaceuticals B.v. Questions
Matisse Pharmaceuticals B.V.'s website is matisse-pharma.com
Matisse Pharmaceuticals B.V.'s LinkedIn profile is https://nl.linkedin.com/company/matissepharmaceuticals
Matisse Pharmaceuticals B.V. has
9 employees.
View email and phone details for 9
employees at Matisse Pharmaceuticals B.V..
Matisse Pharmaceuticals B.V.'s industry is
Pharmaceutical Manufacturing
Matisse Pharmaceuticals B.V.'s top competitors are
Orca Therapeutics,
Interdos,
Dgr Pharma,
Infarama,
Neuroplast,
Basic Pharma,
Cimaas Bv,
Innocore Pharmaceuticals,
Byondis,
Pathofinder.
Matisse Pharmaceuticals B.V.'s categories are Pharmaceutical Manufacturing
Matisse Pharmaceuticals B.V.'s founding year is 2014
